TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis

Liping Zhang(Shandong University), Lei Yan(Shandong University)
International Journal of Oncology
March 4, 2020
Cited by 38


Related Papers